Related Experiment Video
Updated: Oct 3, 2026

Studying Food Reward and Motivation in Humans
Published on: March 19, 2014
Onset of drowsiness and satiation after meals with different energy contents
U Landström1, A Knutsson, M Lennernäs
1National Institute for Working Life, Box 7654, S-907 13 Umeå, Sweden.
Abstract:
The investigation consisted of a laboratory study with 10 healthy subjects who were both sleep and food deprived prior to each experimental condition. The aim of the study was to investigate the importance of energy content and the bulk of food on wakefulness and satiation. Each subject was tested in four conditions, each with equal food composition but different energy amounts: 100, 500 and 1000 kcal and 100 kcal with low bulk content. Recordings and ratings of wakefulness and satiations were carried out throughout the investigation, starting 30 minutes before and continuing until 90 minutes after intake of the food alternatives. No differences in wakefulness could be observed after the four food alternatives. However, subjects rated themselves as more satiated after the food alternatives with higher energy content and higher bulk.
More Related Videos
07:33Sucrose Preference and Novelty-Induced Hypophagia Tests in Rats using an Automated Food Intake Monitoring System
Published on: May 8, 2020
08:07Simultaneous Detection of c-Fos Activation from Mesolimbic and Mesocortical Dopamine Reward Sites Following Naive Sugar and Fat Ingestion in Rats
Published on: August 24, 2016
Related Concept Videos
Metabolic States of the Body: The Absorptive State
Regulation of Food Intake
Metabolic States of the Body: The Postabsorptive State
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Energy Balance
Metabolic States of the Body: Fasting and Starvation
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...